Anaconda Aortic Stent-Graft:<b>Single-Center Experience of a New Commercially Available Device for Abdominal Aortic Aneurysms</b>

Saratzis, Nikolaos; Melas, Nikolaos; Saratzis, Athanasios; Lazarides, John; Ktenidis, Kiriakos; Tsakiliotis, S.; Kiskinis, Dimitrios

doi:10.1583/07-2277.1

Cited by 59 publications

(73 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Indications and specifications have been described elsewhere [16] . Procedures were performed in an operating theatre under general anaesthesia using fluoroscopic control and non-ionic contrast.…”

Section: Aneurysm Repair Procedures Endovascular Repairmentioning

confidence: 99%

Intervention Associated Acute Kidney Injury and Long-Term Cardiovascular Outcomes

et al. 2015

Self Cite

View full text Add to dashboard Cite

Background: Acute kidney injury (AKI) has been associated with all-cause short- and long-term mortality. However, its association with cardiovascular (CV) events remains unclear. We sought to investigate this in patients undergoing open (OAR) or endovascular (EVAR) abdominal aortic aneurysm repair, as they are likely to develop both AKI and CV morbidity. A meta-analysis was subsequently performed to confirm this in other CV-interventions. Methods: AKI-incidence was assessed in a multicentre-cohort of 1,068 patients undergoing EVAR (947 individuals) or OAR electively using the ‘Acute Kidney Injury Network' criteria. A composite-endpoint was used, consisting of non-fatal myocardial infarction (MI), stroke, vascular event, hospitalisation due to heart failure and CV death. A systematic literature review identified studies reporting AKI-incidence and CV events. Risk ratios (RRs) at 1 and 5 years were combined using meta-analysis. Results: During a median follow-up of 62 months (range 11-121), AKI was associated with CV events on adjusted (for CV risk-factors) analyses (Incidence 36% of EVAR, 32% of OAR patients; hazard ratio 1.73, 95% CI 1.06-3.39, p = 0.03) for the overall population. In the meta-analysis, 7 studies reported incidence of MI on 23,936 patients 1-year after coronary intervention (PCI) with a pooled RR of 1.76 (95% CI 1.45-2.83, p < 0.001); at 2 years, 3 studies reported MI incidence on 17,773 patients after PCI with a pooled RR of 1.34 (95% CI 1.10-1.63, p = 0.003). MI-incidence was reported 5 years after cardiac surgery by 3 studies (33,701 patients) with a pooled RR of 1.60 (95% CI 1.43-1.81). Conclusion: AKI is associated with long-term CV events after surgery or endovascular intervention.

show abstract

Section: Aneurysm Repair Procedures Endovascular Repairmentioning

confidence: 99%

Intervention Associated Acute Kidney Injury and Long-Term Cardiovascular Outcomes

et al. 2015

Self Cite

View full text Add to dashboard Cite

show abstract

“…New endovascular techniques allow us to overcome difficult anatomy. A new generation of stent-grafts can be used in the treatment of patients who have highly angulated aorta or those with short aneurysm neck [7].…”

mentioning

confidence: 99%

Comparison of Endovascular Aneurysm Repair with Open Repair in Patients with Abdominal Aortic Aneurysm in Our Own Material in Years 2002-2011

Gnus¹,

Ferenc²,

Dziewiszek³

et al. 2015

Adv Clin Exp Med

View full text Add to dashboard Cite

Background. Endovascular abdominal aortic aneurysm repair has become an alternative to open surgical repair of abdominal aortic aneurysm since the early 1990s. The conventional method remains the gold standard in the treatment of Abdominal Aortic Aneurysm (AAA); however, a large percentage of patients do not qualify for this treatment due to the high risk of perioperational death and complications. Objectives. The objective of this work was to compare AAA surgeries performed by both classical and endovascular methods in years 2002-2011. Material and Methods. Medical documentation of elective AAA patients undergoing surgical treatment was retrospectively analyzed on the basis of archive-and computer database data. The analysis included the patients' demographics, internal disease burden, as well as causes of deaths and complications within 30 days after the procedure and 1 year follow-up. Results. Thirty-day and 1-year mortality rates in patients treated in the elective setting were 1.5% and 8.7% for endovascular method and 4.0% and 15.7% for the open method. The comparison of mortality rates in 115 high-risk patients undergoing elective OR treatment with 275 high-risk treatment patients undergoing EVAR surgery (7.8% vs. 1.5%, 8.7% vs. 15.7%, p < .01) showed that the endovascular method significantly reduced the mortality in the latter group. Conclusions. Endovascular treatment is an attractive option in AAA; especially in heavily burdened patients, because it definitely reduces mortality. EVAR was found to be advantageous over OR in case of high-risk patients (Adv Clin Exp Med 2015, 24, 3, 475-479).

show abstract

“…1,2 Over the last few years, technological advancements and further clinical research have mainly focused on the development and introduction of new generation stent graft devices, such as those with enhanced flexibility to overcome challenging anatomies. [3][4][5][6][7][8][9][10][11] Hostile infrarenal aortic anatomy is a major cause of failure of EVAR [12][13][14][15][16][17] and for that reason a significant proportion of patients with adverse aneurysm morphology still benefit from conventional open repair. Unfavorable anatomical conditions, such as severe infrarenal aortic neck angulation (Ͼ60°) and dilated aortic neck, are associated with a high incidence of proximal type I endoleak 17 and stent graft migration, 17,18 respectively.…”

mentioning

confidence: 99%

“…Other anatomical limitations, such as a very short proximal neck and severe angulation of the iliac arteries have also been described. Cumulative clinical experience and technical advances with the evolution of newer more flexible stent graft devices 3,5,[7][8][9]19,20 have all been working together to circumvent adverse aneurysm morphologies, with a view to expanding the applications of endovascular treatments for aortic aneurysms. Recently, late generation stent grafts, like the Endurant (Medtronic Cardiovascular, Santa Rosa, Calif) device, have been developed to overcome complex aortic morphologies and improve EVAR outcomes.…”

mentioning

confidence: 99%

Early results of the Endurant endograft system in patients with friendly and hostile infrarenal abdominal aortic aneurysm anatomy

Georgiadis

Trellopoulos

Antoniou

et al. 2011

Journal of Vascular Surgery

View full text Add to dashboard Cite

Early (12 months) results suggest similar clinical performance of the Endurant stent graft system in endovascular treatment of AAAs with friendly and hostile anatomies, however, demonstrating more intra- and perioperative adversities for the last group. Larger prospective studies or even randomized trials comparing different new generation graft models are required to evaluate the comparable long-term results and possible expansion of EVAR indications for this specific endograft in adverse anatomies.

show abstract

Anaconda Aortic Stent-Graft:Single-Center Experience of a New Commercially Available Device for Abdominal Aortic Aneurysms

Abstract: The Anaconda stent-graft appears both safe and effective in terms of midterm clinical outcome and compares favorably with previously reported EVAR results. The ability to reposition the stent-graft is a particular advantage.

Cited by 59 publications

References 25 publications

Intervention Associated Acute Kidney Injury and Long-Term Cardiovascular Outcomes

Intervention Associated Acute Kidney Injury and Long-Term Cardiovascular Outcomes

Comparison of Endovascular Aneurysm Repair with Open Repair in Patients with Abdominal Aortic Aneurysm in Our Own Material in Years 2002-2011

Early results of the Endurant endograft system in patients with friendly and hostile infrarenal abdominal aortic aneurysm anatomy

Contact Info

Product

Resources

About